Meitar Law Offices has been recently involved in a range of complex and high-value work for large pharmaceutical and life sciences companies. Corporate transactions are at the heart of the firm’s work; prime examples being a $1.6bn merger between two pharmaceutical companies and the $300m acquisition of an early-stage life sciences company. The firm also handles intellectual property protection and management, advice on clinical trials, product liability disputes, and regulatory matters. Key advisers to entrepreneurs, start-ups, and mature companies on M&A deals, Haim Gueta and Boaz Mizrahi co-lead the practice alongside experienced litigator Ron Peleg. Technology and IP partner Rebecca Fisher also stands out.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Pfizer, Inc.
  • Integra Lifesciences
  • Medivators Inc.
  • MediWound Ltd.
  • Gamida Cell Ltd.
  • Access Industries Inc.
  • Ayala Pharmaceuticals, Inc
  • CaribouBio, Inc.
  • Corcept Therapeutics, Inc.
  • Senseera Ltd.

Highlight-Mandate

  • Representing Mayo Clinic in the Data agreement with Shiba medical hospital.
  • Represented Innovalve Bio Medical Ltd. in an option agreement to be acquired by a leading pharmaceutical company.
  • Represented Taro Pharmaceuticals in the merger with sun pharma.

Anwält*innen

Praxisleitung

Haim Gueta; Boaz Mizrahi; Ron Peleg

Weitere Kernanwält*innen

Rebecca Fisher